Psychopharmacology of aging: current trends

Reduction of dyskinesias and psychiatric disability with clozapine over different time courses.

Journal of psychopharmacology (Oxford, England)·2012

Developments in perforator imaging for the anterolateral thigh flap: CT angiography and CT-guided stereotaxy.

Microsurgery·2008

Analysis of the promoters and 5'-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes.

Genes and immunity·2006

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Neurology·2004

Behavioral symptoms in mild cognitive impairment.

Neurology·2004

Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.

Neurochemical research·2003

Anticonvulsant drugs, behavior, and cognitive abilities.

Current developments in psychopharmacology·1981

Behavioral effects of opiates: a pharmacogenetic analysis.

Current developments in psychopharmacology·1981

Comparative psychopharmacology.

Current developments in psychopharmacology·1981

Drug-induced tardive dyskinesia.

Current developments in psychopharmacology·1981

Chronopharmacological studies of neuroleptics.

Current developments in psychopharmacology·1981

Sex steroid control of intermale fighting in mice.

Current developments in psychopharmacology·1979

A cost-effective conventional endpoint PCR assay for HLA-B*13:01 genotyping to guide personalized dapsone therapy in leprosy in low-resource settings.

Personalized medicine·2026

Variation in Attribute Prioritization and Design of Discrete Choice Experiments Across Pharmaceuticals and Medical Devices Patient Preference: A Systematic Review.

Patient preference and adherence·2026

Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, and Atrial Fibrillation: An Umbrella Review With Methodological Appraisal of Overlapping Meta-Analyses.

Cureus·2026

A transcriptomics-based computational drug repurposing pipeline identifies simvastatin and primaquine as therapeutics for endometriosis.

iScience·2026

Evaluating seltorexant as a treatment option for major depressive disorder.

Expert review of neurotherapeutics·2026

Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.

International journal of obesity (2005)·2026

Related Experiment Videos

Psychopharmacology of aging: current trends

Related Concept Videos

Reduction of dyskinesias and psychiatric disability with clozapine over different time courses.

Developments in perforator imaging for the anterolateral thigh flap: CT angiography and CT-guided stereotaxy.

Analysis of the promoters and 5'-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes.

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.

Behavioral symptoms in mild cognitive impairment.

Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.

Anticonvulsant drugs, behavior, and cognitive abilities.

Behavioral effects of opiates: a pharmacogenetic analysis.

Comparative psychopharmacology.

Drug-induced tardive dyskinesia.

Chronopharmacological studies of neuroleptics.

Sex steroid control of intermale fighting in mice.

A cost-effective conventional endpoint PCR assay for HLA-B*13:01 genotyping to guide personalized dapsone therapy in leprosy in low-resource settings.

Variation in Attribute Prioritization and Design of Discrete Choice Experiments Across Pharmaceuticals and Medical Devices Patient Preference: A Systematic Review.

Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, and Atrial Fibrillation: An Umbrella Review With Methodological Appraisal of Overlapping Meta-Analyses.

A transcriptomics-based computational drug repurposing pipeline identifies simvastatin and primaquine as therapeutics for endometriosis.

Evaluating seltorexant as a treatment option for major depressive disorder.

Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.

Related Experiment Videos

Psychopharmacology of aging: current trends

Related Concept Videos

Related Articles